Related references
Note: Only part of the references are listed.AND-ASPEN and ESPEN consensus, and GLIM criteria for malnutrition identification in AECOPD patients: a longitudinal study comparing concurrent and predictive validity
Bruna Espindola de Araujo et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2022)
Impact of malnutrition diagnosed using Global Leadership Initiative on Malnutrition criteria on clinical outcomes of patients with gastric cancer
Li-Bin Xu et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2022)
Relationship between malnutrition and the presence of symptoms of anxiety and depression in hospitalized cancer patients
Francisco Jose Sanchez-Torralvo et al.
SUPPORTIVE CARE IN CANCER (2022)
The GLIM criteria for defining malnutrition can predict physical function and prognosis in patients with cardiovascular disease
Yoshifumi Kootaka et al.
CLINICAL NUTRITION (2021)
Feasibility of a multimodal intervention on malnutrition in patients with lung cancer during primary anti-neoplastic treatment
Randi Tobberup et al.
CLINICAL NUTRITION (2021)
The GLIM criteria as an effective tool for nutrition assessment and survival prediction in older adult cancer patients
Xi Zhang et al.
CLINICAL NUTRITION (2021)
Evaluation of the Global Leadership Initiative on Malnutrition Criteria Using Different Muscle Mass Indices for Diagnosing Malnutrition and Predicting Survival in Lung Cancer Patients
Liangyu Yin et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2021)
Prevalence and prognostic implications of malnutrition as defined by GLIM criteria in elderly patients with heart failure
Susumu Hirose et al.
CLINICAL NUTRITION (2021)
PG-SGA SF in nutrition assessment and survival prediction for elderly patients with cancer
Qi Zhang et al.
BMC GERIATRICS (2021)
A poorer nutritional status impacts quality of life in a sample population of elderly cancer patients
Tatiane Correia Rios et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2021)
Mapping Health-Related Quality of Life, Anxiety, and Depression in Patients with Head and Neck Cancer Diagnosed with Malnutrition Defined by GLIM
Ylva Tiblom Ehrsson et al.
NUTRIENTS (2021)
Prevalence of Malnutrition Diagnosed with GLIM Criteria and Association with Activities of Daily Living in Patients with Acute Stroke
Masafumi Nozoe et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2021)
Comparison of the GLIM, ESPEN and ICD-10 Criteria to Diagnose Malnutrition and Predict 30-Day Outcomes: An Observational Study in an Oncology Population
Shay Poulter et al.
NUTRIENTS (2021)
Impact of Baseline Nutrition and Exercise Status on Toxicity and Outcomes in Phase I and II Oncology Clinical Trial Participants
Rishi Jain et al.
ONCOLOGIST (2020)
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study
Alessio Cortellini et al.
SCIENTIFIC REPORTS (2020)
Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors
Benoit Roch et al.
LUNG CANCER (2020)
Global Leadership Initiative on Malnutrition (GLIM): Guidance on Validation of the Operational Criteria for the Diagnosis of Protein-Energy Malnutrition in Adults
Heather Keller et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2020)
Malnutrition Screening and Assessment in the Cancer Care Ambulatory Setting: Mortality Predictability and Validity of the Patient-Generated Subjective Global Assessment Short form (PG-SGA SF) and the GLIM Criteria
Lynette M. De Groot et al.
NUTRIENTS (2020)
Reliability and validity of the new VikingSlice software for computed tomography body composition analysis
Manta Ozola-Zalite et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2019)
GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community
T. Cederholm et al.
CLINICAL NUTRITION (2019)
Prognostic Value of Sarcopenia in Lung Cancer A Systematic Review and Meta-analysis
Ming Yang et al.
CHEST (2019)
The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer
J. H. R. J. Degens et al.
LUNG CANCER (2019)
Exploring the dietary protein intake and skeletal muscle during first-line anti-neoplastic treatment in patients with non-small cell lung cancer
Randi Tobberup et al.
CLINICAL NUTRITION ESPEN (2019)
Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review
Frederic Pamoukdjian et al.
CLINICAL NUTRITION (2018)
Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy
Shlomit Strulov Shachar et al.
CLINICAL CANCER RESEARCH (2017)
Muscle mass and association to quality of life in non-small cell lung cancer patients
Asta Bye et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?
Toshio Kato et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value
Drazena Srdic et al.
SUPPORTIVE CARE IN CANCER (2016)
Nutritional Risk Screening Predicts Tumor Response in Lung Cancer Patients
Petr Illa et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2015)
Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
Olivier Mir et al.
PLOS ONE (2012)
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
M. J. Proctor et al.
BRITISH JOURNAL OF CANCER (2011)
Sarcopenia: European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft et al.
AGE AND AGEING (2010)
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
S. Antoun et al.
ANNALS OF ONCOLOGY (2010)
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
Carla M. M. Prado et al.
CLINICAL CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. M. Prado et al.
LANCET ONCOLOGY (2008)
Share Paper
